labetalol has been researched along with Hypotension, Postural in 8 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 12 patients with resistant hypertension labetalol was added to existing therapy." | 7.66 | Labetalol in resistant hypertension. ( Hedstrand, H, 1982) |
| "In 12 patients with resistant hypertension labetalol was added to existing therapy." | 3.66 | Labetalol in resistant hypertension. ( Hedstrand, H, 1982) |
| " Dosage ranged from 100 to 2400 mg per day (mean 654 mg per day) and treatment was continued for between 6 and 18 months (mean 7." | 1.27 | Side-effects with long-term labetalol: an open study of 251 patients in a single centre. ( Tcherdakoff, P, 1983) |
| "Postural hypotension is a common side effect observed in the treatment of hypertension with various drugs." | 1.27 | Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine. ( Bartsch, W; Böhm, E; Hooper, RG; Sponer, G; Strein, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tcherdakoff, P | 1 |
| Hedstrand, H | 1 |
| Dollery, CT | 1 |
| Louis, WJ | 1 |
| Brignell, MJ | 1 |
| McNeil, JJ | 1 |
| Christophidis, N | 1 |
| Vajda, FJ | 1 |
| Frick, MH | 1 |
| Pörsti, P | 1 |
| Bartsch, W | 1 |
| Sponer, G | 1 |
| Strein, K | 1 |
| Böhm, E | 1 |
| Hooper, RG | 1 |
1 trial available for labetalol and Hypotension, Postural
| Article | Year |
|---|---|
Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Ethanolamines; Female; | 1976 |
7 other studies available for labetalol and Hypotension, Postural
| Article | Year |
|---|---|
Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
Topics: Adult; Aged; Asthma; Ethanolamines; Female; Humans; Hypertension; Hypotension, Orthostatic; Labetalo | 1983 |
Labetalol in resistant hypertension.
Topics: Adult; Antihypertensive Agents; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; H | 1982 |
Closing remarks: current status of labetalol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Ethanol | 1976 |
Labetalol in hypertension.
Topics: Adolescent; Adrenergic alpha-Antagonists; Antihypertensive Agents; Drug Evaluation; Ethanolamines; F | 1977 |
Labetalol in hypertension.
Topics: Dose-Response Relationship, Drug; Ethanolamines; Female; Humans; Hypertension; Hypotension, Orthosta | 1978 |
Labetalol for hypertension.
Topics: Ethanolamines; Humans; Hypertension; Hypotension, Orthostatic; Labetalol | 1978 |
Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
Topics: Animals; Blood Pressure; Carbazoles; Carvedilol; Disease Models, Animal; Guanethidine; Hypotension, | 1987 |